I find this most interesting as the last antibiotic was develop by a drug  
company at a research cost of 100 million dollars.  After their discovery,  
they commented that they would no longer do any further research with  
antibiotics.  It was just too expensive, with so little in return, as far a  
payback.
Best Wishes
 
 
In a message dated 3/12/2014 1:41:20 P.M. Central Daylight Time,  
[email protected] writes:

 
http://news.nd.edu/news/46745-notre-dame-chemists-discover-new-class-of-anti
biotics/


A  team of University of Notre Dame researchers led by _Mayland Chang_ 
(http://chemistry.nd.edu/people/mayland-chang/)  and_Shahriar  Mobashery_ 
(http://chemistry.nd.edu/people/shahriar-mobashery/)  have  discovered a new 
class 
of antibiotics to fight bacteria such as  methicillin-resistant 
Staphylococcus aureus (MRSA)  and other drug-resistant bacteria that threaten 
public 
health. Their research  is published in the Journal of the American Chemical 
Society in an article  titled “_Discovery  of a New Class of Non-beta-lactam 
Inhibitors of Penicillin-Binding Proteins  with Gram-Positive Antibacterial 
Activity_ 
(http://pubs.acs.org/doi/abs/10.1021/ja500053x?prevSearch=%5BContrib%3A+Mobashery%5D&searchHistoryKey)
 .”



Reply via email to